Oramed Pharmaceuticals, Inc. (ORMP)
4.13
+0.01
(+0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.14
+0.01
(+0.24%)
After-Hours: 20:00
Oramed Pharmaceuticals Price : 4.13 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 4.10 | 4.17 | 4.06 | 4.13 | 115663.0 |
| Oct 22, 2026 | 4.09 | 4.21 | 4.075 | 4.12 | 97615.00 |
| Oct 21, 2026 | 4.16 | 4.21 | 4.06 | 4.14 | 84413.00 |
| Oct 20, 2026 | 4.06 | 4.22 | 4.054 | 4.15 | 142343.0 |
| Oct 19, 2026 | 4.08 | 4.10 | 3.89 | 4.06 | 162758.0 |
| Oct 16, 2026 | 4.19 | 4.19 | 3.99 | 4.07 | 277085.0 |
| Oct 15, 2026 | 4.18 | 4.28 | 4.15 | 4.18 | 128184.0 |
| Oct 14, 2026 | 4.12 | 4.22 | 4.12 | 4.14 | 146568.0 |
| Oct 13, 2026 | 4.28 | 4.28 | 4.145 | 4.17 | 113751.0 |
| Oct 12, 2026 | 4.34 | 4.35 | 4.21 | 4.27 | 73194.00 |
| Oct 09, 2026 | 4.17 | 4.34 | 4.15 | 4.33 | 193502.0 |
| Oct 08, 2026 | 4.36 | 4.36 | 4.16 | 4.20 | 166473.0 |
| Oct 07, 2026 | 4.425 | 4.45 | 4.35 | 4.37 | 84753.00 |
| Oct 06, 2026 | 4.55 | 4.575 | 4.36 | 4.38 | 96232.00 |
| Oct 05, 2026 | 4.50 | 4.57 | 4.43 | 4.55 | 104134.0 |
| Oct 02, 2026 | 4.53 | 4.565 | 4.39 | 4.49 | 178321.0 |
| Oct 01, 2026 | 4.65 | 4.685 | 4.430 | 4.48 | 272601.0 |
| Sep 30, 2026 | 4.70 | 4.72 | 4.66 | 4.67 | 129151.0 |
| Sep 29, 2026 | 4.76 | 4.795 | 4.67 | 4.69 | 170670.0 |
| Sep 28, 2026 | 4.70 | 4.78 | 4.65 | 4.75 | 110385.0 |
| Sep 25, 2026 | 4.80 | 4.90 | 4.72 | 4.73 | 177851.0 |
| Sep 24, 2026 | 4.71 | 4.878 | 4.65 | 4.79 | 149321.0 |
| Sep 23, 2026 | 4.74 | 4.74 | 4.62 | 4.72 | 134796.0 |
| Sep 22, 2026 | 4.71 | 4.84 | 4.71 | 4.75 | 145231.0 |
| Sep 21, 2026 | 4.76 | 4.76 | 4.67 | 4.70 | 98047.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 72.61 |
| Corcept Therapeutics, Inc. | 85.86 |
| Veru, Inc. | 2.24 |
| Johnson & Johnson | 263.81 |
| Eli Lilly & Co. | 1273.46 |
Price Related Metrics
| PE Ratio | 1.005 |
| Price to Book Value | 0.5375 |
| Earnings Yield | 99.53% |
| Market Cap | 170.63M |
| Normalized PE Ratio | 3.940 |